Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Margin

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Margin(%) 0.151.01

What is the latest Core EBITDA Margin ratio of GENPHARMASEC ?

The latest Core EBITDA Margin ratio of GENPHARMASEC is 0.15 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar20240.15
Mar20231.01

How is Core EBITDA Margin of GENPHARMASEC Trending?

Years Core EBITDA Margin % Change
Mar2024 0.15
-85.15
Mar2023 1.01 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Margin ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹114.1 Cr 0.5% -4.2% -11.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,902.5 Cr 4.6% -1.6% 37.7% Stock Analytics
KIRI INDUSTRIES ₹3,170.0 Cr 3.4% -5.4% 53.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,971.3 Cr -6.3% -7% -6.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,158.5 Cr 3.7% 11.1% 40.5% Stock Analytics
BODAL CHEMICALS ₹968.4 Cr -2.3% 7.2% -6.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

0.5%

-4.2%

-11.8%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses